BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24713841)

  • 1. Do larger periprocedural fluid volumes reduce the severity of post-endoscopic retrograde cholangiopancreatography pancreatitis?
    DiMagno MJ; Wamsteker EJ; Maratt J; Rivera MA; Spaete JP; Ballard DD; Elmunzer J; Saini SD
    Pancreas; 2014 May; 43(4):642-7. PubMed ID: 24713841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
    Law R; Leal C; Dayyeh BA; Leise MD; Balderramo D; Baron TH; Cardenas A
    Liver Transpl; 2013 Dec; 19(12):1354-60. PubMed ID: 24115362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
    Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
    Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Neutrophil-Lymphocyte Ratio as an Early Predictive Marker of the Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Lee SH; Lee TY; Cheon YK
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056321
    [No Abstract]   [Full Text] [Related]  

  • 6. Moderate and severe postendoscopic retrograde cholangiopancreatography pancreatitis despite prophylactic pancreatic stent placement: the effect of early prophylactic pancreatic stent dislodgement.
    Moffatt DC; Pradermchai K; Avula H; Sherman S; Fogel EL; Lehman GA
    Can J Gastroenterol; 2011 Apr; 25(4):215-9. PubMed ID: 21523263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic stents in the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography].
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Orv Hetil; 2021 Jan; 162(1):31-38. PubMed ID: 33388737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced risk of post ERCP pancreatitis in statin users.
    Hadi YB; Naqvi SF; Abdelqader A; Kupec J; Nasr J
    BMC Gastroenterol; 2020 Apr; 20(1):125. PubMed ID: 32326889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of greater intravenous volume infusion with shorter hospitalization for patients with post-ERCP pancreatitis.
    Sagi SV; Schmidt S; Fogel E; Lehman GA; McHenry L; Sherman S; Watkins J; Coté GA
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1316-20. PubMed ID: 24372871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early measures of hemoconcentration and inflammation are predictive of prolonged hospitalization from post- endoscopic retrograde cholangiopancreatography pancreatitis.
    Coté GA; Sagi SV; Schmidt SE; Lehman GA; McHenry L; Fogel E; Watkins J; Sherman S
    Pancreas; 2013 Jul; 42(5):850-4. PubMed ID: 23648842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study.
    Cárdenas-Jaén K; Archibugi L; Poropat G; Korpela T; Maisonneuve P; Aparicio JR; Udd M; Stimac D; Arcidiacono PG; De Pretis N; Valente R; Di Giulio E; Casellas JA; Kylänpää L; Hauser G; Mariani A; Gabbrielli A; Löhr M; Vanella G; Rainio M; Brozzi L; Arnelo U; Fagerström N; Capurso G; de-Madaria E
    Dig Endosc; 2021 May; 33(4):639-647. PubMed ID: 32713065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin consumption and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Martínez-Moneo E; Cárdenas-Jaén K; Fernández-Laso AB; Millastre-Bocos J; Torralba-Gallego A; Martín-Arriero S; Alfaro-Almajano E; García-Rayado G; de-Madaria E
    Pancreatology; 2020 Jul; 20(5):801-805. PubMed ID: 32448748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
    Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early pancreatic stent placement in wire-guided biliary cannulation: A multicenter retrospective study.
    Hakuta R; Hamada T; Nakai Y; Isayama H; Kogure H; Takahara N; Mizuno S; Yagioka H; Togawa O; Matsubara S; Ito Y; Yamamoto N; Tada M; Koike K
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1116-1122. PubMed ID: 30152138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis.
    Lin Y; Liu X; Cao DQ; Tang JH; Wen JJ; Li TF; Liu PF; Xia TS
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5185-5190. PubMed ID: 29228432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive correlation between pancreatic volume and post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Maruyama H; Shiba M; Ishikawa-Kakiya Y; Kato K; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Yamagami H; Tanigawa T; Watanabe T; Yamamoto A; Kabata D; Shintani A; Fujiwara Y
    J Gastroenterol Hepatol; 2020 May; 35(5):769-776. PubMed ID: 31618801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Shin SH; So H; Cho S; Kim N; Baik GH; Lee SK; Park DH
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1201-1207. PubMed ID: 31830336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.